Abiopharma

🔍 Xu Derek (Director)

Company: Airship AI Holdings, Inc. (AISP)

Report Date: 2026-04-20

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-20 | Code: H | shares_owned_after: 5,222,920.00 | Footnotes: F1
• Holds 1,344,951 shares of Warrants at $1.77 per share (Derivative)
  Date: 2026-04-20 | Code: H | Expires: 2028-05-08 | Exercise: 2023-12-21 | shares_owned_after: 1,344,951.00 | Footnotes: F2
• Holds 1,630,642 shares of Earnout Rights (Derivative)
  Date: 2026-04-20 | Code: H | shares_owned_after: 1,630,642.00 | Footnotes: F3, F3, F3
• Holds 100,000 shares of Options at $2.86 per share (Derivative)
  Date: 2026-04-20 | Code: H | Expires: 2034-08-16 | shares_owned_after: 100,000.00 | Footnotes: F4
• Holds 50,000 shares of Options at $4.25 per share (Derivative)
  Date: 2026-04-20 | Code: H | Expires: 2035-09-03 | shares_owned_after: 50,000.00 | Footnotes: F4

Footnotes:

• F1: Includes shares of common stock of the Issuer received on December 21, 2023, as consideration pursuant to that certain Merger Agreement, dated as of June 27, 2023 (as amended on September 22, 2023 and as may be further amended and/or restated from time to time, the "Merger Agreement"), by and among Airship AI Holdings, Inc., a Delaware corporation (the "Issuer") (formerly known as BYTE Acquisition Corp., a Cayman Island exempted company limited by shares, prior to its domestication as a Delaware corporation), BYTE Merger Sub, Inc., a Washington corporation and a direct, wholly-owned subsidiary of the Issuer, and Airship AI, Inc., a Washington company (formerly known as Airship AI Holdings, Inc., "Airship AI"). The Reporting Person received the reported shares in exchange for shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.
• F2: Represents warrants to purchase shares of common stock of the Issuer received by the Reporting Person on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of warrants to purchase shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.
• F3: Pursuant to earnout provisions in the Merger Agreement, the holder of such Earnout Rights is entitled to receive shares of common stock of the Issuer upon the occurrence of certain operating performance and share price performance milestones during the applicable earnout periods set forth in the Merger Agreement.
• F4: Options vest quarterly over 4 years.
• REMARKS: The Reporting Person files this Form 4 to correctly state the Warrants(2) expiration date as 05/08/2028.